Have a different future in mind? Put it to a vote.
One future. Endless possibilities. What's your call?
0 / … answered
JUMP TO1–100
Prediction & discussion
Speculative forecasts, not established facts.
Saved in this browser. Account saving across devices is not available yet.
Health & Longevity · #23
By 2044, Original Medicare will begin reimbursing an FDA-authorized blood test that screens asymptomatic adults for multiple cancer types.
Current status · February 2026: Federal law establishes a Medicare coverage pathway for qualifying multi-cancer screening tests from 1 January 2029, subject to authorization and coverage requirements. Public Law 119-75, section 6221
What counts
Use the effective date of actual reimbursement eligibility under Original Medicare. The test must have the relevant FDA authorization; individual Medicare Advantage extras do not count.
This is a speculative forecast, not an established fact. Vote to see community results.
Discussion
Discuss the evidence, assumptions and uncertainty. Sign in to add your reasoning.
Be the first to share your reasoning.
✦
Your future is still unwritten.
Make your first call and it will appear here.
Explore the future by topic
Read predictions, examine what would count, and join the discussion.